Literature DB >> 26947218

Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang.

Adriana Amaro1, Silvana Chiara2, Ulrich Pfeffer3.   

Abstract

Colorectal cancer is characterized by exquisite genomic instability either in the form of microsatellite instability or chromosomal instability. Microsatellite instability is the result of mutation of mismatch repair genes or their silencing through promoter methylation as a consequence of the CpG island methylator phenotype. The molecular causes of chromosomal instability are less well characterized. Genomic instability and field cancerization lead to a high degree of intratumoral heterogeneity and determine the formation of cancer stem cells and epithelial-mesenchymal transition mediated by the TGF-β and APC pathways. Recent analyses using integrated genomics reveal different phases of colorectal cancer evolution. An initial phase of genomic instability that yields many clones with different mutations (big bang) is followed by an important, previously not detected phase of cancer evolution that consists in the stabilization of several clones and a relatively flat outgrowth. The big bang model can best explain the coexistence of several stable clones and is compatible with the fact that the analysis of the bulk of the primary tumor yields prognostic information.

Entities:  

Keywords:  Big bang; Carcinogenesis; Chromosome instability; Colorectal cancer; Microsatellite instability; Tumor evolution; Tumor heterogeneity

Mesh:

Year:  2016        PMID: 26947218     DOI: 10.1007/s10555-016-9606-4

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  14 in total

Review 1.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

Review 2.  Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.

Authors:  Evangelos Koustas; Eleni-Myrto Trifylli; Panagiotis Sarantis; Nikolaos Papadopoulos; Eleni Karapedi; Georgios Aloizos; Christos Damaskos; Nikolaos Garmpis; Anna Garmpi; Kostas A Papavassiliou; Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 3.  Mediterranean Diet: Prevention of Colorectal Cancer.

Authors:  Micah G Donovan; Ornella I Selmin; Tom C Doetschman; Donato F Romagnolo
Journal:  Front Nutr       Date:  2017-12-05

4.  Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumors.

Authors:  Jun Cheng; Xuekun Song; Lu Ao; Rou Chen; Meirong Chi; You Guo; Jiahui Zhang; Hongdong Li; Wenyuan Zhao; Zheng Guo; Xianlong Wang
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

Review 5.  Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?

Authors:  Chiara Molinari; Giorgia Marisi; Alessandro Passardi; Laura Matteucci; Giulia De Maio; Paola Ulivi
Journal:  Int J Mol Sci       Date:  2018-11-23       Impact factor: 5.923

Review 6.  Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.

Authors:  Veronika Skarkova; Vera Kralova; Barbora Vitovcova; Emil Rudolf
Journal:  Cells       Date:  2019-03-12       Impact factor: 6.600

7.  A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo.

Authors:  Adriana Amaro; Giovanna Angelini; Valentina Mirisola; Alessia Isabella Esposito; Daniele Reverberi; Serena Matis; Massimo Maffei; Walter Giaretti; Maurizio Viale; Rosaria Gangemi; Laura Emionite; Simonetta Astigiano; Michele Cilli; Beatrice E Bachmeier; Peter H Killian; Adriana Albini; Ulrich Pfeffer
Journal:  Oncotarget       Date:  2016-10-18

8.  Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53.

Authors:  Keli Chen; Fengjiao Zhang; Jie Ding; Yonghao Liang; Zetao Zhan; Yizhi Zhan; Long-Hua Chen; Yi Ding
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

9.  Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.

Authors:  Pooja Ghatalia; Chad H Smith; Arthur Winer; Jiangtao Gou; Lesli A Kiedrowski; Michael Slifker; Patricia D Saltzberg; Nicole Bubes; Fern M Anari; Vineela Kasireddy; Asya Varshavsky; Yang Liu; Eric A Ross; Wafik S El-Deiry
Journal:  Front Oncol       Date:  2019-01-17       Impact factor: 6.244

10.  Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma.

Authors:  Francesca Piaggio; Veronica Tozzo; Cinzia Bernardi; Michela Croce; Roberto Puzone; Silvia Viaggi; Serena Patrone; Annalisa Barla; Domenico Coviello; Martine J Jager; Pieter A van der Velden; Michael Zeschnigk; Davide Cangelosi; Alessandra Eva; Ulrich Pfeffer; Adriana Amaro
Journal:  Cancers (Basel)       Date:  2019-10-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.